Volume 3.02 | Jan 17

Pancreatic Cell News 3.02, January 17, 2012
     In this issue: Publications | Industry News | Policy News | Events | Jobs 
Cell Therapy News on Facebook  Pancreatic Cell News on Twitter
Scientists Shed New Light on Link between ‘Killer Cells’ and Diabetes
Killer T-cells in the human body which help protect us from disease can inadvertently destroy cells that produce insulin, new research has uncovered. [Press release from King’s College London discussing online prepublication in Nature Immunology] Press Release | Abstract

Webinar: Groundbreaking Applications for Feeder-Free hESC & hiPSC Culture. Watch Now.
PUBLICATIONS (Ranked by Impact Factor of the Journal)


RAE1ε Ligand Expressed on Pancreatic Islets Recruits NKG2D Receptor-Expressing Cytotoxic T Cells Independent of T Cell Receptor Recognition
With a transgenic mouse expressing the NKG2D ligand retinoic acid early transcript 1ε (RAE1ε) in β-islet cells of the pancreas, investigators found that RAE1 expression was sufficient to induce the recruitment of adoptively transferred cytotoxic T lymphocytes to islets. [Immunity] Abstract

Chronic Treatment with a Glucokinase Activator Delays the Onset of Hyperglycemia and Preserves Beta Cell Mass in the Zucker Diabetic Fatty Rat
Here, scientists report the effects of chronic glucokinase activator treatment on the development of hyperglycemia and beta cell loss in the male Zucker diabetic fatty rat. [Diabetologia] Abstract

Hedgehog Signals Inhibit Postnatal Beta Cell Neogenesis from Adult Rat Exocrine Pancreas In Vitro
Considering the inhibitory functions of hedgehog signaling in early and mid-stage pancreatic development, researchers questioned whether it also operates in transdifferentiating acinar cells and whether its modulation would influence postnatal beta cell neogenesis in vitro. [Diabetologia] Abstract

Involvement of Thioredoxin-Interacting Protein (TXNIP) in Glucocorticoid-Mediated Beta Cell Death
Researchers’ objective was to elucidate the mechanisms by which glucocorticoid hormones affect beta cell survival with a specific emphasis on the role of TXNIP in beta cell apoptosis. [Diabetologia] Abstract

Nano-Scale Encapsulation Enhances Allograft Survival and Function of Islets Transplanted in a Mouse Model of Diabetes
Investigators aimed to test whether early islet loss can be limited and transplant survival improved by the application of conformal nano-coating layers to islets. [Diabetologia] Abstract

Inhibition of Gsk3β Activity Improves β-Cell Function in c-KitWv/+ Male Mice
The purpose of this study was to examine if c-KitWv/+ mutation-induced β-cell dysfunction is associated with downregulation of the phospho-Akt/Gsk3β pathway in c-KitWv/+ male mice. [Lab Invest] Abstract


KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma
Here, researchers report that pancreas-targeted IKK2/β inactivation inhibited NF-κB activation and pancreatic ductal adenocarcinoma (PDAC) development in KrasG12D and KrasG12D;Ink4a/ArfF/F mice, demonstrating a mechanistic link between IKK2/β and KrasG12D in PDAC inception. [Cancer Cell] Abstract

New Gene-Immunotherapy Combining TRAIL-Lymphocytes and EpCAMxCD3 Bispecific Antibody for Tumor Targeting
Here, lymphocytes were transduced with TRAIL lentivirus and the anti-tumor effect in presence and absence of EpCAMxCD3 was evaluated in vitro and in xenograft studies using EpCAM-positive pancreatic and prostate cancer cells. [Clin Cancer Res] Abstract

Multicellular Tumor Spheroid Model to Evaluate Spatio-Temporal Dynamics Effect of Chemotherapeutics. Application to the Gemcitabine/CHK1 Inhibitor Combination in Pancreatic Cancer.
Researchers analyzed the effect of gemcitabine alone and in combination with the CHIR-124 CHK1 inhibitor in a Capan-2 pancreatic cell multicellular tumor spheroid model. [BMC Cancer] Abstract

Nestin as a Novel Therapeutic Target for Pancreatic Cancer via Tumor Angiogenesis
In the present study, scientists analyzed the expression and roles of nestin in angiogenesis of pancreatic ductal adenocarcinomas, and determined whether nestin is a potential target for inhibiting tumor angiogenesis using a gene silencing strategy. [Int J Oncol] Abstract

Use AggreWell™ for Reproducible, Uniform Embryoid Bodies


UCSF, Sanofi Collaborate to Find New Diabetes Cures
This $3.1 million collaboration will bring together scientists in three University of California, San Francisco (UCSF) labs with deep understanding of the biology of beta cells with Sanofi researchers who are experienced in developing potential drug candidates into actual therapies. [University of California, San Francisco] Press Release

Pioneering Diabetes Research Earns University of Texas Southwestern Medical Center Scientist State’s Top Honor for Medicine
Dr. Scherer is one of four winners of the 2012 Edith and Peter O’Donnell Awards presented by The Academy of Medicine, Engineering and Science of Texas. [The University of Texas Southwestern Medical Center] Press Release

Islet Sciences, Inc. Selects NeoStem’s Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
NeoStem’s cell therapy manufacturing division, Progenitor Cell Therapy (PCT), announced an agreement whereby PCT will provide contract manufacturing and regulatory services related to the development of Islet Sciences – PTM, which will be an injectable suspension of microencapsulated insulin-producing, pancreatic islet cells which are harvested from designated pathogen free pigs. [NeoStem, Inc.] Press Release

Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes
Oramed Pharmaceuticals Inc. announced that it has filed a provisional patent application with the United States Patent and Trademark Office for a combination therapy of its lead compound, ORMD-0801 in combination with its oral exenatide formulation, ORMD-0901. [Oramed Pharmaceuticals Inc.] Press Release


Limited Competition: Continuation of the Clinical Islet Transplantation (CIT) Consortium Data Coordinating Center (U01) (RFA-DK-12-501) [National Institutes of Health, United States]

Limited Competition for the Data Coordinating Center for Type 1 Diabetes TrialNet (UC4) (RFA-DK-12-503) [National Institutes of Health, United States]

Center for Scientific Review; Notice of Closed Meetings (FR Doc No: 2012-732) [National Institutes of Health, United States]

National Institutes of Health (United States)

Food and Drug Administration (United States)
Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

National Health Service (United Kingdom)

Therapeutic Goods Administration (Australia)

NEW Keystone Symposia on Molecular and Cellular Biology: Cancer and Metabolism
February 12-17, 2012
Banff, Canada

Visit our events page to see a complete list of events in the pancreatic cell community.

Research and Development Technologist, hPSC Media (STEMCELL Technologies) 

Scientist – Pluripotent Stem Cells (STEMCELL Technologies)

Scientific Marketing Communications Specialist (STEMCELL Technologies)

Research Technologist, Manufacturing Sciences (STEMCELL Technologies)

Business Analyst – Product Management (STEMSOFT Software)

Postdoctoral Fellowship in Stem Cell Biology (The University of British Columbia)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Jobs are categorized regionally:
United States, Canada, Europe, Asia Pacific

Visit here to post your career opportunities.

Have we missed an important article or publication in Pancreatic Cell News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Pancreatic Cell News: Archives | Events | Contact Us